Charles Schwab’s Miromatrix Medical Inc. Common Stock MIRO Stock Holding History

Charles Schwab’s Portfolio MIRO Stock Details MIRO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-11,036	Closed	-$13.4K	–	3581
2023 Q3	$13.4K	Hold	11,036	–	–	﹤0.01%	3544
2023 Q2	$19.3K	Hold	11,036	–	–	﹤0.01%	3565
2023 Q1	$18.5K	Hold	11,036	–	–	﹤0.01%	3514
2022 Q4	$33K	Hold	11,036	–	–	﹤0.01%	3437
2022 Q3	$49K	Buy	+11,036	New	+$35.7K	﹤0.01%	3336

Charles Schwab's MIRO Position: Q4 2023 in Review

Charles Schwab sold out of Miromatrix Medical Inc. Common Stock (MIRO) in Q4 2023, closing a stake of 11,036 shares — an estimated $13.4K sold.

Charles Schwab first reported a position in MIRO in Q3 2022 and held it in 5 quarters. The position peaked at $49K in Q3 2022. 0 funds tracked by Wall St. Rank hold MIRO as of Q4 2023.

Charles Schwab reported no remaining Miromatrix Medical Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
Charles Schwab sold 11,036 Miromatrix Medical Inc. Common Stock shares in Q4 2023, an estimated $13.4K.
Charles Schwab first reported a position in Miromatrix Medical Inc. Common Stock in Q3 2022 and held it in 5 quarters.
Charles Schwab's Miromatrix Medical Inc. Common Stock position peaked at $49K in Q3 2022.
0 funds tracked by Wall St. Rank held Miromatrix Medical Inc. Common Stock as of Q4 2023.

Based on Charles Schwab's 13F filing for Q4 2023, filed 6 Feb 2024.